Biochip technologies in cancer research

被引:61
作者
Kallioniemi, OP [1 ]
机构
[1] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
biochip; bioinformatics; genomics; microarray; proteomics; single-nucleotide polymorphism;
D O I
10.3109/07853890109002069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Development of high-throughput 'biochip' technologies has dramatically enhanced our ability to study biology and explore the molecular basis of disease. Biochips enable massively parallel molecular analyses to be carried out in a miniaturized format with a very high throughput. This review will highlight applications of the various biochip technologies in cancer research, including analysis of 1) disease predisposition by using single-nucleotide polymorphism (SNP) microarrays, 2) global gene expression patterns by cDNA microarrays, 3) concentrations, functional activities or interactions of proteins with proteomic biochips, and 4) cell types or tissues as well as clinical endpoints associated with molecular targets by using tissue microarrays, One can predict that individual cancer risks can, in the future, be estimated accurately by a microarray profile of multiple SNPs in critical genes. Diagnostics of cancer will be facilitated by biochip readout of activity levels of thousands of genes and proteins. Biochip diagnostics coupled with informatics solutions will form the basis of individualized treatment decisions for cancer patients.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 14 条
  • [1] Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
    Bärlund, M
    Forozan, F
    Kononen, J
    Bubendorf, L
    Chen, YD
    Bittner, ML
    Torhorst, J
    Haas, P
    Bucher, C
    Sauter, G
    Kallioniemi, OP
    Kallioniemi, A
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) : 1252 - 1259
  • [2] Molecular classification of cutaneous malignant melanoma by gene expression profiling
    Bittner, M
    Meitzer, P
    Chen, Y
    Jiang, Y
    Seftor, E
    Hendrix, M
    Radmacher, M
    Simon, R
    Yakhini, Z
    Ben-Dor, A
    Sampas, N
    Dougherty, E
    Wang, E
    Marincola, F
    Gooden, C
    Lueders, J
    Glatfelter, A
    Pollock, P
    Carpten, J
    Gillanders, E
    Leja, D
    Dietrich, K
    Beaudry, C
    Berens, M
    Alberts, D
    Sondak, V
    Hayward, N
    Trent, J
    [J]. NATURE, 2000, 406 (6795) : 536 - 540
  • [3] Antibodies in diagnostics - from immunoassays to protein chips
    Borrebaeck, CAK
    [J]. IMMUNOLOGY TODAY, 2000, 21 (08): : 379 - 382
  • [4] Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5
  • [5] Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
    Diehn, M
    Eisen, MB
    Botstein, D
    Brown, PO
    [J]. NATURE GENETICS, 2000, 25 (01) : 58 - 62
  • [6] Eisen MB, 1999, METHOD ENZYMOL, V303, P179
  • [7] Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
    Golub, TR
    Slonim, DK
    Tamayo, P
    Huard, C
    Gaasenbeek, M
    Mesirov, JP
    Coller, H
    Loh, ML
    Downing, JR
    Caligiuri, MA
    Bloomfield, CD
    Lander, ES
    [J]. SCIENCE, 1999, 286 (5439) : 531 - 537
  • [8] Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry
    Griffin, TJ
    Smith, LM
    [J]. TRENDS IN BIOTECHNOLOGY, 2000, 18 (02) : 77 - 84
  • [9] KALLIONIEMI OP, 2001, IN PRESS HUM MOL GEN
  • [10] Tissue microarrays for high-throughput molecular profiling of tumor specimens
    Kononen, J
    Bubendorf, L
    Kallioniemi, A
    Bärlund, M
    Schraml, P
    Leighton, S
    Torhorst, J
    Mihatsch, MJ
    Sauter, G
    Kallioniemi, OP
    [J]. NATURE MEDICINE, 1998, 4 (07) : 844 - 847